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Abstract
Background: Electronic healthcare databases are of increasing importance in health research and mortality is one
of the most relevant outcomes. However, data in these databases need to be validated, since they are often
generated for reimbursement purposes. The aims of this study were to compare mortality figures from the German
Pharmacoepidemiological Research Database (GePaRD) on an aggregated level with external data from the Federal
Statistical Office of Germany (FSOG) and to assess consistency of records of death from core data and hospital data
within GePaRD.
Methods: The study population comprised insurants of four statutory health insurances providing data for GePaRD
with either continuous insurance coverage from January 1st to December 31st 2006 or until death. The sex-specific
mortality rate, stratified and standardized by age, and the percentage of hospital deaths among all deaths was
compared with data from the FSOG. Furthermore, the agreement between the dates of death according to hospital
data and core data was assessed within GePaRD.
Results: The study population comprised 12,033,622 insurants. Compared to FSOG data, the age-standardised mortality
rate in GePaRD was 21 % and 29 % lower in women and men, respectively. Regional analyses also indicated lower
mortality rates in all federal states except for Bremen, where the age-standardised mortality rate was similar to FSOG
data for both sexes. The percentage of hospital deaths among all deaths corresponded well with external data. The
proportion of inpatient deaths also recorded in the health insurance core data was 98.5 %. Furthermore, 94 % of dates
of death documented in hospital agreed with the dates of death according to the health insurance core data.
Conclusions: The lower mortality rates in almost all federal states might result from the higher socioeconomic status
of the GePaRD study population compared to the overall population in Germany. In the federal state of Bremen, where
socioeconomic representativeness is higher due to additional inclusion of two local health insurances, the mortality
rates were in good accordance with external data. Agreement of the percentage of hospital deaths among all deaths
between GePaRD and national statistics suggested completeness of outpatient mortality information.
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Background
Large healthcare databases are increasingly being used
in the field of health services research, providing an un-
biased insight into routine care [1]. However, since data
in these databases are generated mainly for documenta-
tion and reimbursement purposes and not for research
purposes, they need to be validated [2]. One of the most
essential information in health research is mortality. It is
of most importance when evaluating the benefit, risk or
quality of care regarding (new) drugs or other interven-
tions or health care services. Furthermore, mortality is
also important for the statistical analyses as it can lead
to censoring in Kaplan Meier analyses.
In data of German statutory health insurances (SHIs),
a death is documented in the core data as a potential
reason for leaving the insurance company. For persons
dying in hospital, a death is additionally documented in
the hospital data. While the date of death in hospital
data is based on reports from the hospital, in core data
it is based on notifications of the insurance company by
other sources.
Information of administrative databases can ultimately
only be validated based on a record linkage with another
data source containing the gold standard information [3].
However, this is associated with very high data protection
requirements in Germany and also very expensive and
time-consuming. Therefore a record linkage can often not
be realised. In this context, a comparison of the relevant
aggregated information, e.g. the mortality rate in this
study, with a national statistic can give first insights into
the completeness and validity of the database.
The aims of this study were to compare mortality figures
of the German Pharmacoepidemiological Research Data-
base (GePaRD) with external data from the Federal Statis-
tical Office of Germany (FSOG) on an aggregated level. In
contrast, in a second step, we compared two sources of in-




Source of data for this study was GePaRD that has been
built by the Leibniz Institute for Prevention Research and
Epidemiology – BIPS [4]. GePaRD consists of claims data
from four German SHIs which included data of more than
twelve million persons in 2006 from all geographical re-
gions of Germany. Membership in an SHI is compulsory
in Germany for employees below an annual income
threshold (47,250€ in 2006). Subjects with higher incomes
can choose private health insurance providers instead of
an SHI and are somewhat underrepresented in SHIs
[4, 5]. However, a considerable proportion of these per-
sons remain voluntary members of SHIs, most often be-
cause SHIs provide free health insurance for unemployed
family members (children and spouse) whereas in private
health insurance plans all family members have to be paid
for. About 70 million people (85 % of the German popula-
tion) are SHI members, including about five million vol-
untary members, children and patients who are retired or
unemployed. On the other hand, there may also be some
overrepresentation of patients with middle to higher so-
cioeconomic status in GePaRD, since three of the four
SHIs contributing to the database are more likely to insure
patients of middle to higher socioeconomic status. How-
ever, the database also includes patients from one local in-
surance company which traditionally insures patients of
lower socioeconomic status [6].
Two large SHIs contributing to GePaRD cover all geo-
graphical regions of Germany. Two smaller SHIs mainly
include insurants from Bremen and Lower Saxony. The
database comprises information on demographic charac-
teristics of the health insurance members, information
on their outpatient physician contacts, hospital admis-
sions and outpatient prescriptions.
Inclusion and exclusion criteria
The study population consisted of insurants with either
a continuous insurance period from January 1st to
December 31st 2006 or to a documented date of death in
this year. Children born in the given year were included
in the study population if they were continuously in-
sured until December 31st 2006 or until a documented
date of death in this year. Insurants without valid infor-
mation on sex, year of birth, or region of residence were
excluded from the study population. Co-insured family
members of one small SHI were excluded from the study
population, since the cause for the end of the insurance
period in the core data was not specified for this group.
Identification of deaths and the date of death in GePaRD
Deaths in GePaRD were identified if the reason for the
end of the insurance period or the reason for discharge
from hospital was “death”. The date of death was defined
as the end date of the insurance period which indicated
death and, for hospital deaths, the end date of the
hospital stay which ended with death.
External comparison data
To compare the mortality indicators calculated in our
study with external data, the respective mortality indica-
tors were obtained from the FSOG as reference informa-
tion [7]. In Germany, the reporting of death certificates to
the FSOG is regulated by law. First, deaths have to be re-
ported to the registry office, where deaths are registered
and certified. The registry offices forward the information
to the regional statistical offices as well as to the health
authority. Afterwards, the mortality information of the dif-
ferent regional statistical offices is collected at the FSOG.
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Statistical analysis
The annual mortality rate per 100,000 persons was cal-
culated stratified by sex, age and federal state by dividing
the number of deaths by the number of insurants of the
respective stratum. 95 %-confidence intervals (CIs) for
mortality rates were calculated by the substitution method,
assuming that the number of events is Poisson distributed
[8]. In order to adjust for age differences between the
GePaRD study population and the population distribution
of Germany, mortality rates estimated in GePaRD were
age-standardised for men and women and compared to
the respective age-standardised mortality rate from the
FSOG. CIs for age-standardised rates were calculated ac-
cording to the gamma distribution [9]. Furthermore, the
percentage of hospital deaths among all deaths was calcu-
lated stratified by sex and age. As measures of internal
consistency, the proportion of deaths documented by the
hospitals which were also recorded as deceased persons
according to the health insurance core data was calculated
and the difference between the date of death obtained
from the hospital data and the date of death obtained
from the core data were calculated.
All analyses were performed using SAS 9.1 (SAS Insti-
tute, Inc, Cary NC).
Ethics and legal regulations
Use of the data for research purposes was approved by the
contributing SHIs and by local and federal government
authorities. In accordance with §75 of volume 10 of the
German Social Insurance Code, informed consent of the
insurants was not required. Since the study was based on
routinely collected pseudonymized data and persons were
not contacted, ethical approval was not needed.
Results
The influence of the in- and exclusion criteria on the size
of the study population is shown in the sample flow chart
(Fig. 1). The study population comprised 12,033,622 per-
sons of whom 44.9 % were male (Table 1). The age-
standardised mortality rate in GePaRD in 2006 was 621.9
per 100,000 persons (95 % CI: 609.5-634.6) for women
and 506.7 per 100,000 persons (95 % CI: 498.4-515.1) for
men. These rates were 21 % and 29 % lower for women
and men, respectively, compared to the data from FSOG
(data not shown). The age-stratified mortality rates
showed an increase with age in a similar fashion as the
national data, however, somewhat lower estimates for per-
sons in GePaRD were evident in patients aged 55 years or
older (Fig. 2). Also sex-stratified standardised mortality
rates by federal state showed lower mortality estimates
than the FSOG in all federal states except Bremen, where
the mortality rate was in good accordance with the data of
the FSOG (Fig. 3 a and b). The age-stratified percentage of
hospital deaths among all deaths was high in children aged
younger than five years, decreased afterwards and rose
again to 47-55 % in persons aged 60–85 years (Fig. 4).
These results compared well with the data of the FSOG in
both sexes, especially in persons aged older than 40 years.
The percentage of hospital deaths among all deaths was
45.8 % in women and 50.7 % in men and was also in good
accordance with the data of the FSOG, where a percentage
of hospital deaths among all deaths of 44.7 % in women
and 50.5 % in men were observed.
Almost 99 % of the deaths recorded in the hospital
data were also recorded in the core data of the health in-
surances. The date of death in the hospital data was con-
cordant with the date of death in the core data in 94.2 %
of all deaths (Table 2). Deviations in the date of death
were mostly equal or below 5 days and involved more
than 5 days in only 0.1 % of all cases.
Discussion
Our comparison of age-standardised mortality rates in
GePaRD with national data for Germany showed a some-
what lower mortality rate for both sexes. This was also
replicated in regional analyses by federal state except for
the state of Bremen. The percentage of hospital deaths
among all deaths was in good accordance with external
Fig. 1 Size of the study population selected from GePaRD when
applying the in- and exclusion criteria
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data. Furthermore, a high internal consistency of the re-
cords of deaths was observed.
We assume that the lower estimates of the age-
standardised mortality in GePaRD result from the higher
socioeconomic status of the GePaRD study population
compared to the general population in Germany. The
socioeconomic status is known to be an important pre-
dictor for morbidity and mortality [10, 11]. In GePaRD,
insurants with middle to higher socioeconomic status
were overrepresented compared to the general popula-
tion, since more than 90 % of the total study population
were insured by two SHIs which traditionally insure
people with middle to higher socioeconomic status [6].
An exception is the federal state of Bremen, where the
SHI distribution in the study population was more bal-
anced due to the inclusion of two local insurance com-
panies, one of which traditionally insures people with a
low or middle socioeconomic status [6]. In Bremen, the
age-standardised mortality rates compared well with
national statistics, supporting the assumption of socio-
economic status differences as an explanation of the
lower mortality rates observed in GePaRD.
Table 1 Age and sex distribution of the study population in GePaRD in 2006
Women Men All
n % n % n %
Age group
0-39 years 2,703,519 40.8 2,445,760 45.3 5,149,279 42.9
40-49 years 1,186,434 17.9 899,125 16.6 2,085,559 17.3
50-59 years 958,088 14.5 748,431 13.9 1,706,519 14.2
60-69 years 928,988 14.0 746,414 13.8 1,675,402 13.9
70-79 years 525,294 7.9 422,678 7.8 947,972 7.9
80-89 years 278,391 4.2 127,583 2.4 405,974 3.4
≥90 years 48,396 0.7 14,521 0.3 62,917 0.5
All 6,629,110 100 5,404,512 100a 12,033,622 100a
Mean age (Mean, SD) 43.7 22.2 40.8 22.4 42.4 22.3
aPercentages do not sum up to 100 % due to rounding
Fig. 2 Age- and sex-stratified mortality per 100,000 persons in Germany and in GePaRD in 2006 on a logarithmic scale. FSOG: Federal Statistical
Office of Germany. GePaRD: German Pharmacoepidemiological Research Database
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With regard to regional variations, deviations of age-
standardised mortality rates between the GePaRD study
population and the general population were more pro-
nounced in the federal states of the former German
Democratic Republic compared to the other federal
states. After the German reunification, the population of
the former German Democratic Republic, previously
covered by state insurance, was enrolled in the system
of SHIs existing in the former Federal Republic of
Germany. While the local SHIs enrolled most of the
population, presumably predominantly younger and
healthier insurants switched to alternative SHIs, among
them to those which traditionally insure people with
middle to higher socioeconomic status. Studies suggest
that persons who change the health insurance company
are younger, healthier and have a higher socioeconomic
status compared to those who do not change the health
insurance company [12]. This selection mechanism
could have been even stronger in the former German
Democratic Republic, which would explain the more
pronounced differences between the GePaRD study
population and the general population in these federal
states. Furthermore, the coverage of the population in
these federal states by GePaRD is comparatively low,
which also might have contributed to the more pro-
nounced differences.
Fig. 3 Age-standardised mortality per 100,000 persons in Germany and in GePaRD stratified by federal state in 2006 for a women and b men.
FSOG: Federal Statistical Office of Germany. GePaRD: German Pharmacoepidemiological Research Database
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The percentage of hospital deaths among all deaths
agreed well with national data in all age groups. Espe-
cially in the older age groups, the percentages of hospital
deaths in GePaRD were similar to the national data,
whereas the small deviations observed in the younger
age groups are probably due to fluctuations resulting
from the overall small number of deaths in these youn-
ger age groups. Given the fact that hospital data are
likely to provide complete information about deaths, the
similar percentage of patients dying in the hospital
compared to national data suggests that also records of
outpatient mortality are rather complete in GePaRD.
However, an undercoding of deaths, which could also be
one of the reasons for the lower mortality rates observed
in this study, cannot be ruled out.
Strength and limitations
The main strength of this study is the large sample which
allowed robust estimations of mortality indicators. Since
information on the socioeconomic status is rather incom-
plete in administrative data and mortality estimates strati-
fied by socioeconomic status are lacking in the data of the
FSOG, an adjustment for the socioeconomic status could
not be carried out. Direct external validation of mortality
associated information by medical chart review was not
possible within the framework of this study.
Conclusions
The mortality estimates were overall in good accordance
with external data. The observed differences were ex-
pected due to a higher socioeconomic status of our study
population. Comparison of mortality related information
in core and hospital data of the database demonstrated a
high consistency. The percentage of hospital deaths
among all deaths in GePaRD agreed well with national
statistics, indirectly also providing evidence for complete-
ness of outpatient mortality information. Therefore, this
study provides first evidence for complete and valid mor-
tality related information in GePaRD. However, studies
based on a record linkage with a data source containing
the gold standard are needed to further elucidate the val-
idity of the respective information.
Fig. 4 Age- and sex-stratified percentage of hospital deaths among all deaths in Germany and in GePaRD in 2006. FSOG: Federal Statistical Office
of Germany. GePaRD: German Pharmacoepidemiological Research Database
Table 2 Agreement between the date of death recorded in
hospital data and the date of death recorded in core data in
GePaRD in 2006
Difference n = 42,188
n %
−1 to −5 days 2 0.00
No difference 39,757 94.24
+1 to +5 days 2,389 5.66
+6 to +10 days 19 0.05
+11 to +20 days 8 0.02
+21 to +50 days 11 0.03
> +50 days 2 0.00
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